Patient Engagement June 30, 2020
Sara Heath

Most patients who purchase medications from other countries face high drug costs, are low-income, but have high patient activation.

Some 1.5 percent of adult patients regularly taking a prescription medication purchase that medication from somewhere outside the United States, a trend that is largely driven by low-income patients with high patient activation, according to new research in JAMA Network Open.

By and large, patients purchase their medications outside the US to avoid the high patient financial responsibility usually tied to these medications in the States.

In 2018 alone, the US spent $3.65 trillion on healthcare, or 17 percent of the gross domestic product, the researchers reported. Much of that can be attributed to a 25 percent spike in the cost...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Patient / Consumer, Pharma / Biotech, Pricing / Spending, Provider
Former Bristol Myers CEO tapped as Novartis’ next board chair
The Power of Drug Discovery with Philip Tagari
Novartis raises forecasts as top drug sales beat Wall Street estimates
Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & more
AI Ushers in HPC Revival Says TACC’s Dan Stanzione

Share This Article